Jj

Jj News

India Rejects J&J Plea to Extend Patent on Key Tuberculosis Drug, Drop in Prices Expected
World

India Rejects J&J Plea to Extend Patent on Key Tuberculosis Drug, Drop in Prices Expected

The patent on the drug made India dependent on drug supplies from J&J, the latest decision will pave the way for generic versions in the local market, increasing access

COVID-19 Fact Check: You are fully vaccinated when you get two doses of a COVID-19 vaccine
science

COVID-19 Fact Check: You are fully vaccinated when you get two doses of a COVID-19 vaccine

The vaccines offer strong protection against serious illness but US health officials now recommend boosters for some people at higher risk for severe illness from COVID-19.

US begins booster shot drive for a chosen few, who is eligible for the third COVID-19 vaccine?
science

US begins booster shot drive for a chosen few, who is eligible for the third COVID-19 vaccine?

People 18 to 49 who got their Pfizer shots at least six months ago with risky health problems can consider the booster based on their individual benefits and risks.

India may try to find 'middle ground' for usage and export of J&J single-shot jab
India

India may try to find 'middle ground' for usage and export of J&J single-shot jab

A strategy needs to be put in place where India may take a share of the monthly production of J&J’s vaccine for domestic use, said a senior government official privy to developments on this front

Two Johnson & Johnson doses provide 75 percent protection against COVID symptoms, finds official trial
World

Two Johnson & Johnson doses provide 75 percent protection against COVID symptoms, finds official trial

The CDC said it expects a second dose of the J&J vaccine will be required, but that it needs more data before making a firm recommendation.

Sputnik Light, J&J take another step towards joining India's COVID vaccine arsenal
India

Sputnik Light, J&J take another step towards joining India's COVID vaccine arsenal

While Sputnik Light has received DCGI's approval for phase-3 bridging trials, around 35 lakh doses of J&J’s vaccine have been dispatched for final round of quality and safety checks in HP

India's daily coronavirus cases dip below 40,000 for second day; 9 states, UTs still reporting upward trend
India

India's daily coronavirus cases dip below 40,000 for second day; 9 states, UTs still reporting upward trend

The number of people who have recuperated from the disease surged to 3,10, 99,771, while the case fatality rate stands at 1.34 per cent, the data stated.

Explained: Johnson & Johnson says its COVID-19 vaccine is effective against Delta variant; what this means
India

Explained: Johnson & Johnson says its COVID-19 vaccine is effective against Delta variant; what this means

J&J has indicated that it is in talks with the Indian government to bring its vaccine to the country of 1.3 billion people

With eyes on China, Quad nations launch 1 bn vaccine plan, project grouping as 'vital arena for cooperation'
World

With eyes on China, Quad nations launch 1 bn vaccine plan, project grouping as 'vital arena for cooperation'

PM Narendra Modi said the first Quad summit shows that the group has come of age and will now remain an important pillar of stability in the region. It was attended by US president Joe Biden, Australian PM Scott Morrison and Japanese PM Yoshihide Suga

EU drug regulator approves J&J's one-shot COVID-19 vaccine for adults
World

EU drug regulator approves J&J's one-shot COVID-19 vaccine for adults

The European Medicines Agency said it was recommending the COVID-19 jab for those over 18 “after a thorough evaluation” found it met the criteria for efficacy, safety and quality

Johnson & Johnson to stop selling talc-based baby powder in US, Canada; says demand drops due to 'misinformation'
Business

Johnson & Johnson to stop selling talc-based baby powder in US, Canada; says demand drops due to 'misinformation'

Johnson & Johnson on Tuesday announced it would stop selling its talc Baby Powder in the United States and Canada, saying demand had dropped in the wake of what it called “misinformation” about the product’s safety amid a barrage of legal challenges

Faulty hip implants: Delhi HC asks Johnson & Johnson for interim payment of Rs 25 lakh to 4 patients
Business

Faulty hip implants: Delhi HC asks Johnson & Johnson for interim payment of Rs 25 lakh to 4 patients

The court's direction came after Johnson & Johnson said it was willing to pay Rs 25 lakh as compensation to the patients who were affected by the implants.

Johnson & Johnson’s baby shampoo samples fail Rajasthan drug watchdog's quality tests; company rejects findings
Business

Johnson & Johnson’s baby shampoo samples fail Rajasthan drug watchdog's quality tests; company rejects findings

The Rajasthan Drugs Control Organisation’s notice said that the samples of Johnson & Johnson’s baby shampoofailed the quality test

Johnson & Johnson baby powder case: Action will be taken after sample test, says Himachal drug controller Navneet Marwaha
India

Johnson & Johnson baby powder case: Action will be taken after sample test, says Himachal drug controller Navneet Marwaha

The samples were seized after a report by a London-based news agency, Reuters, claimed that Johnson & Johnson's raw talc and finished powders sometimes tested positive for small amounts of (cancer-causing) asbestos for the last few decades.

Samples of Johnson & Johnson baby powder to be tested as drug inspectors examine mfg facilities: Report
Business

Samples of Johnson & Johnson baby powder to be tested as drug inspectors examine mfg facilities: Report

Johnson & Johnson in India did not have any immediate comment on the reports of sample seizures by Indian authorities.

Johnson and Johnson: Drug regulator likely to seize talcum powder samples for testing in countrywide raids today
India

Johnson and Johnson: Drug regulator likely to seize talcum powder samples for testing in countrywide raids today

India’s drug regulator is likely to investigate Johnson and Johnson baby powder following recent reports that said the company knew for decades about the presence of cancer-causing asbestos in the product.

India's drug regulator says Reuters report on Johnson & Johnson baby powder 'under consideration'
Business

India's drug regulator says Reuters report on Johnson & Johnson baby powder 'under consideration'

Johnson & Johnson said in a statement that the Reuters article, which was published on Friday, “is one-sided, false and inflammatory.”

Johnson & Johnson knew about cancer-causing asbestos lurking in its baby powder since decades, says report; company shares nosedive
World

Johnson & Johnson knew about cancer-causing asbestos lurking in its baby powder since decades, says report; company shares nosedive

Shares of Johnson & Johnson fell 10 percent on Friday and were on track to post their biggest percentage drop in more than 16 years, after Reuters reported that the pharma major knew for decades that cancer-causing asbestos was present in its Baby Powder.

SC puts off Jayalalithaa case hearing to Nov 23
Politics

SC puts off Jayalalithaa case hearing to Nov 23

The Supreme Court has put off to November 23 the hearing in the case where Karnataka government has challenged the Karnataka state high court verdict acquitting Tamil Nadu Chief Minister J.Jayalalithaa